Nitika Pharmaceutical Specialities Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 14-12-2024
- Paid Up Capital ₹ 2.14 Cr
as on 14-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 80.53 Cr
as on 14-12-2024
- Satisfied Charges ₹ 17.77 Cr
as on 14-12-2024
- Revenue 17.44%
(FY 2023)
- Profit 2.39%
(FY 2023)
- Ebitda 20.44%
(FY 2023)
- Net Worth 20.26%
(FY 2023)
- Total Assets 24.35%
(FY 2023)
About Nitika Pharmaceutical Specialities
The Corporate was formerly known as Nitika Pharma Specialities Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.14 Cr.
The company currently has active open charges totaling ₹80.53 Cr. The company has closed loans amounting to ₹17.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravleen Khurana, Manojkumar Agrawal, and Parvinder Singh serve as directors at the Company.
- CIN/LLPIN
U24230MH2011PTC214662
- Company No.
214662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nitika Pharmaceutical Specialities Private Limited offer?
Nitika Pharmaceutical Specialities Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, API (Active Pharmaceutical Ingredients), Swimming Pool & Water Sport Goods, Swimming Pool Chemicals, Fertilizers and Soil Additives, Sulfur Fertilizers, Chemical Reagents & Catalysts.
Who are the key members and board of directors at Nitika Pharmaceutical Specialities?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravleen Khurana  | Director | 12-Mar-2011 | Current |
| Manojkumar Agrawal | Director | 10-Jul-2018 | Current |
| Parvinder Singh | Director | 11-Jul-2019 | Current |
Financial Performance and Corporate Structure Insights of Nitika Pharmaceutical Specialities.
Nitika Pharmaceutical Specialities Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.44% increase. The company also saw a slight improvement in profitability, with a 2.39% increase in profit. The company's net worth Soared by an impressive increase of 20.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nitika Pharmaceutical Specialities?
In 2023, Nitika Pharmaceutical Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 12 Dec 2023 | ₹35.00 Cr | Open |
Bank Of India Creation Date: 20 May 2023 | ₹3.00 Cr | Open |
Axis Bank Limited Creation Date: 22 Mar 2022 | ₹42.19 Cr | Open |
How Many Employees Work at Nitika Pharmaceutical Specialities?
Nitika Pharmaceutical Specialities has a workforce of 122 employees as of Dec 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nitika Pharmaceutical Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nitika Pharmaceutical Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
